Log In
BCIQ
Print this Print this
 

E selectin (SELE) (CD62E)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting E selectin (SELE) (CD62E)

BCIQ
Print ChartPrint this
1 - Hematology 1 - Cancer 2 - Hematology 2 - Cancer 1 - Cardiovascular 1 - Cancer 1 - Cardiovascular
Phase of DevelopmentDiscoveryPreclinicalPhase IPhase I/IIPhase III
Cancer

-

1

2

1

-

Cardiovascular

1

1

-

-

-

Hematology

-

-

2

-

1




 Products Targeting E selectin (SELE) (CD62E)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$340.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/17/2011

$340.0M

Undisclosed

Undisclosed

Get a free BioCentury Trial today